Background and Purpose: Cerebral hypoperfusion has occasionally been reported during essential hypertension. We explored regional cerebral blood flow in a large series of neurologically asymptomatic hypertensive patients to determine relations among cerebral blood flow, concomitant main vascular risk factors, and the most common signs of end-organ damage.
Background and Purpose: Cerebral hypoperfusion has occasionally been reported during essential hypertension. We explored regional cerebral blood flow in a large series of neurologically asymptomatic hypertensive patients to determine relations among cerebral blood flow, concomitant main vascular risk factors, and the most common signs of end-organ damage.
Methods: Regional cerebral blood flow was measured by the`33Xe inhalation method in 101 hypertensive patients without clinically apparent central nervous system involvement, including 39 mild to moderate untreated and 62 mild to severe treated patients.
Results: Compared with age-and sex-matched normal control subjects, cerebral blood flow was significantly reduced in untreated hypertensive patients (P<.01) and to a lesser extent in treated patients (P=.047). Both regional and global cerebral blood flow reductions were observed in approximately one third of patients in both groups. Analysis of variance failed to show significant correlations between cerebral blood flow and total cholesterol concentration, mean arterial blood pressure, duration of disease, or the presence of retinopathy or left ventricular hypertrophy. In the treated group, the quality of control of hypertension significantly influenced both global cerebral blood flow (P=.007) and cerebrovascular resistance (P<.0001).
Conclusions: Focal or diffuse cerebral hypoperfusion is present even in neurologically asymptomatic hypertensive patients, especially when untreated; good control of blood pressure may preserve cerebral perfusion and reduce cerebrovascular resistance. Regional cerebral blood flow examination represents a relatively simple and low-cost technique to explore the perfusional condition of the brain, one of the main target organs of hypertensive disease. (Stroke 1993;24:1148-1153) KEY WoRDs * cerebral blood flow * hypertension * hypoperfusion M ain end-organs of hypertensive disease, such as the retina and the heart, are routinely investigated by morphofunctional techniques. In contrast, available means to study the brain as an end-organ are more limited; they are usually expensive or involve radiation exposure for the patient (eg, computed tomography), and the specificity of the electroencephalogram is generally considered too low for this purpose.
In recent years the growing availability of atraumatic and sensitive methods to assess cerebral metabolism and cerebral blood flow (CBF) (including positron emission tomography, '33Xe clearance, and single-photon emission computed tomography) offered a unique opportunity to better understand cerebral function during either cerebral or systemic disorders. These methods seem adequate to assess cerebrovascular involvement due to hypertension.
Indeed, considerable effort has been expended to define modifications of CBF autoregulation during hypertension by acute manipulation of blood pressure (BP),1-3but it is not feasible to apply such a complex and risk-prone procedure as a screening test on a broad patient population. On the other hand, only a few reports concerning cerebral perfusion in patients with chronic hypertension without acute modifications of BP have appeared. [4] [5] [6] [7] Although the early work by Kety The study was approved by the ethics committee of our institution; all patients gave their informed consent, and women were examined within the first 5 days of their menstrual cycle, according to Italian radiological conventions. We considered it unethical to expose all patients to the radiation involved in brain computed tomographic examination; however, we suggested that it might be useful in patients with significant hypoperfusion. Six patients accepted this procedure; for one patient we were able to obtain a magnetic resonance imaging examination, which was not readily available at the time of the study.
In 63 (62.4%) of the 101 patients continuous-wave Doppler sonography of neck vessels (Angioscan III, Unigon Company) was also performed, disclosing mild to moderate stenosis (less than 70% of lumen reduction) of an internal carotid artery in 4 patients (3 of these in the treated group) and a 50% stenosis of the right subclavian artery in 1 patient (treated group). In 9 more patients slight vessel wall irregularities were found.
In all patients, creatinine clearance, urinalysis, electrocardiogram, funduscopic optic examination, and serum total cholesterol concentration were determined within 1 week from the day of rCBF examination. Serum total cholesterol was measured after overnight fasting by an enzymatic method (Monotest Cholesterol High Performance method; Boehringer Mannheim GmbH, Germany). Hypertensive retinopathy was graded by the two ophthalmologists working in the two referring centers. The results of echocardiography were not taken into account in this study because they were not available in all patients.
To obtain indexes of end-organ damage, a 0/1 score was used to indicate the absence or presence, respec- Values of z were then used in the analysis of variance (ANOVA), which was performed by the Statistical Analysis System (SAS, Cary, NC) on the overall patient group to explore the relations between CBF and known duration of disease, MABP, total cholesterol concentration, presence of retinopathy, and left ventricular hypertrophy. In the treated group, relations between the quality of BP control and MABP, CBF, and CVR were also explored by ANOVA.
Results

Group Comparisons (Absolute Values)
Even without signs or symptoms of cerebral damage at the time of the study as well as in the medical history, mean gCBF was significantly (P<.01) lower in the untreated group (50.2±6.1 ISI) compared with control subjects (54.5 ±5.9 ISI); statistical comparison showed significant CBF reduction in all explored regions and particularly (P<.001) in the left occipital and the right frontoparietal parasagittal regions (Fig 1) ; less pronounced hypoperfusion (P<.02) was found in the left frontotemporal and the right temporo-occipital regions, while the remaining areas exhibited hypoperfusion of intermediate severity (P<.01).
Mean gCBF differed slightly (P=.047) between the treated group (48.6±6.2 ISI) and control subjects (50.7±5.4 ISI). In the treated group the hypoperfused (P<.05; P<.02) areas were found in the left frontal and parietal regions and right frontorolandic regions (Fig 2) .
Deviations of Individual Patients
In the untreated group, 9 (23.1%) patients showed one or more significantly hypoperfused regions (6 patients in one or both frontorolandic areas, 1 in the left parietal region, 2 with a multifocal hypoperfusion pattern) and 6 (15.4%) a reduced gCBF, with an overall frequency of rCBF abnormality of 38.5%. In the treated group, 11 (17.7%) patients had focal hypoperfusion (5 in one or both frontorolandic regions, 3 in one parietal area, 3 with a multifocal hypoperfusion pattern); 11 patients (17.7%) showed a significant decrease of gCBF, with an overall frequency of rCBF abnormality of 35.5%.
Two of the four patients with internal carotid artery stenosis showed global hypoperfusion, one a focal hypoperfusion in the hemisphere contralateral to stenosis, and one a normal rCBF; the patient with subclavian reduce type I error resulting from multiple simultanestenosis had normal rCBF values. values than normal control subjects; treated patients showed a milder reduction. These results agree with previous data on smaller series from our6 as well as from other7 laboratories. Although these differences were small in absolute terms, it should be stressed that the power of our statistics was greatly enhanced by the random selection of control subjects matched for age and sex. This consideration may also explain differences from an early study of gCBF in hypertension,4 which differed from the present investigation also in the number of patients and in their physiological condition (general anesthesia). However, our group may not be considered as representative of the general population of hypertensive patients (patients were not randomized by the two referring centers), and it cannot be ruled out that some patients with silent cerebral infarction were included (because of the lack of morphological examination of the brain in the majority of cases).
It has been suggested that CBF reduction may be due to vascular hypertrophy of either medium-or smallsized vessels and capillaries. '5-'7 This hypothesis is supported by data in stroke-prone spontaneously hypertensive rats (SHR-SP), which showed that rCBF together with glucose utilization was reduced during the development of hypertension and that effective control of hypertension in early stages restored CBF to normal, whereas CBF reduction in old SHR-SP was irreversible because of long-standing arterial wall thickening.18
Another reason for rCBF reduction could be the presence of white matter lesions19-23 or of lacunae24 in hypertensive subjects, which could lead to cortical deafferentation and a decrease in metabolism. The prevalence of white matter lesions reported by Schmidt et al19 was similar to the prevalence of hypoperfusion in our patients, and in two studies asymptomatic lacunae were associated with gray20 and white25 matter CBF reduction. All seven morphological brain examinations available in hypoperfused patients showed neither lacunae (often below the resolution of computed tomographic scanners) nor periventricular white matter lesions.
The most common site of lacunae is the watershed zone between the middle and anterior cerebral arteries (frontal and parietal white matter),20,24 and we found the highest incidence of hypoperfusion in individual cases in areas directly overlying these territories. A previous positron emission tomography study showed frontal hypoperfusion,7 and in a more limited series we observed mainly left frontotemporal hypoperfusion,6 but the number of cases with regional hypoperfusion in each of these studies is too small to provide a definite picture of the topography of rCBF reduction in hypertension.
In treated patients, CBF was dependent on the quality of BP control, suggesting the possibility that effective treatment can preserve CBF5,26 at least in some patients, possibly an indication of regression of simple vascular hypertrophy.8 CVR was progressively higher in patients with intermediate and poor BP control compared with patients with good control, differentiating the three groups even more significantly than CBF; CVR is therefore a sensitive index of cerebrovascular status in hypertensive patients.
The relative preservation of CBF in treated patients might also be due to the effect of drugs such as propanolol26 or clonidine,27 which were reported to increase CBF in hypertensive patients. Those results lack replication, and other studies showed no CBF increase for other commonly used antihypertensive medications.28-30 We were unable to perform an appropriate analysis because too many different drug regimens had been used in this cohort.
Total cholesterol concentration did not correlate with CBF. This would be consistent with data that show that intracranial circulation is relatively unaffected by total cholesterol concentrations,3' even though there is one study suggesting that lower rCBF can be found in hyperlipemic patients. 32 Finally, cerebral hypoperfusion does not parallel the most common signs of damage of both the retina and the heart. Morphofunctional changes associated with hypertension appear to proceed heterogeneously in different target organs; indeed, a lack of correlation between CBF and markers of end-organ damage has also recently been reported in diabetic patients.33
In conclusion, evidence for cerebral hypoperfusion in a large group of both treated and untreated neurologically asymptomatic hypertensive patients is given. In treated patients the quality of BP control is significantly related to both CBF and CVR. Follow-up studies, which are now ongoing at our institution, may add relevant information, especially regarding the question of recovery of rCBF during effective treatment. 
